CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,893 | +61.1% | 31,984 | +85.2% | 0.01% | +55.6% |
| Q2 2023 | $232,096 | -91.1% | 17,269 | -89.0% | 0.01% | -91.7% |
| Q1 2023 | $2,598,451 | +76.1% | 156,722 | +97.6% | 0.11% | +38.5% |
| Q4 2022 | $1,475,519 | +142.3% | 79,329 | +67.0% | 0.08% | +225.0% |
| Q3 2022 | $609,000 | +6.1% | 47,500 | -42.0% | 0.02% | -4.0% |
| Q2 2022 | $574,000 | -33.1% | 81,901 | -20.9% | 0.02% | -32.4% |
| Q1 2022 | $858,000 | +3.5% | 103,494 | -15.4% | 0.04% | -28.8% |
| Q4 2021 | $829,000 | +278.5% | 122,400 | +222.2% | 0.05% | +147.6% |
| Q2 2021 | $219,000 | -13.8% | 37,983 | -31.1% | 0.02% | -12.5% |
| Q1 2021 | $254,000 | +62.8% | 55,100 | +5.0% | 0.02% | -22.6% |
| Q3 2020 | $156,000 | – | 52,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |